Was this drug effective for your ailment?
advertisement

Here is the some steps to help you to save money on Relbovin (50mg) purchase.


Read drug prescription


What is Relbovin (50mg)

Relbovin (50mg) is cancer medication that interferes with the growth of cancer cells and slows their spread in the body.
Relbovin (50mg) is used to treat non-small cell lung cancer.
Relbovin (50mg) is sometimes used in combination with other cancer medications.
Relbovin (50mg) may also be used for other purposes not listed in Relbovin (50mg) guide.

How is Relbovin given?

Relbovin (50mg) is given as an injection through a needle placed into a vein. You will receive this injection in a clinic or hospital setting. The medicine must be given slowly through an IV infusion.
Relbovin (50mg) is usually given once every 7 days. You may also receive the medication once every 6 weeks. Follow your doctor's instructions.
Tell your caregivers if you feel any burning, pain, or swelling around the IV needle when the medicine is injected.
Relbovin (50mg) can lower the blood cells that help your body fight infections. This can make it easier for you to bleed from an injury or get sick from being around others who are ill. To be sure your blood cells do not get too low, your blood will need to be tested on a regular basis. Your cancer treatments may be delayed based on the results of these tests. Do not miss any scheduled visits to your doctor.

Relbovin (50mg) side effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have a serious side effect such as:

Less serious side effects may include:

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
See also: Side effects (in more detail)
advertisement

Relbovin (50mg) dosing

Usual Adult Dose for Non-Small Cell Lung Cancer:

Relbovin 30 mg/m2 administered weekly as a single agent. The recommended method of administration is an intravenous injection over 6 to 10 minutes. In controlled trials, single-agent Relbovin (50mg) was given weekly until progression or dose-limiting toxicity.
or
Relbovin (50mg) 25 mg/m2 weekly in combination with cisplatin. Blood counts should be checked weekly to determine whether dose reductions of Relbovin (50mg) and/or cisplatin are necessary. (In the SWOG study, most patients required a 50% dose reduction of Relbovin (50mg) at day 15 of each cycle and a 50% dose reduction of cisplatin by cycle 3.)
or
Relbovin (50mg) 30 mg/m2 weekly in combination with cisplatin.

Compare prices at online shops


StrengthQuantityPrice, USDCountry
Miracalus Pharma Pvt Ltd
50 mg / 1Vial Injection$149.58India


Select the most affordable brand or generic drug


StrengthQuantityPrice, USDCountry
5 mg10 Tablet$0.47
AVISERA Capsule/ Tablet / 5mg (10 units) $0.42Avalanche Pharmaceuticals
AVISERA tab 5 mg x 10's $0.47Avalanche
5 mg x 100's $4.70
Avisera 5mg TAB / 100 $4.70
AVISERA Capsule/ Tablet / 15mg (10 units) $0.63Avalanche Pharmaceuticals
10 mg/1Vial Injection$37.80
NEOBEN inj 10 mg x 1 mL x 5ml $159.94Neon Labs
Neoben 10mg Injection $16.26Neon Laboratories Ltd
NEOBEN 10MG INJECTION 1 vial(s) (1 ML injection each) $16.26Neon Laboratories Ltd
Neoben 10 mg Injection $0.03
NEOBEN inj 10 mg x 1 mL x 1ml $41.58Neon Labs
VINELBINE inj 20 mg x 5 mL x 5ml $155.75Fresenius Kabi
VINELBINE inj 10 mg x 1 mL x 5ml $163.14Fresenius Kabi
VINELBINE 10MG INJECTION 1 vial(s) (1 ML injection each) $38.37Fresenius Kabi India Pvt Ltd
Vinelbine 50 mg Injection $0.15
10 mg x 1 mL x 5ml $163.14
VINELBINE Injection / 10mg (1ml units) $36.64Dabur Pharmaceuticals
Vinorelbine 50 mg/5 ml vial $27.60
Navelbine 50 mg/5 ml vial $42.00
50 mg/1Vial Injection$171.29
Vinorelmil 50 mg Injection $0.17
Vinorelmil 10 mg Injection $0.03
advertisement

References

  1. "Vinorelbine". https://pubchem.ncbi.nlm.nih.gov/co... (accessed August 28, 2018).
  2. "Vinorelbine". http://www.drugbank.ca/drugs/DB0036... (accessed August 28, 2018).
  3. "Vinorelbine: link to the compound information in wikipedia.". https://en.wikipedia.org/wiki/Vinor... (accessed August 28, 2018).

Relbovin (50mg) - Frequently asked Questions

Can Relbovin (50mg) be stopped immediately or do I have to stop the consumption gradually to ween off?

In some cases, it always advisable to stop the intake of some medicines gradually because of the rebound effect of the medicine.

It's wise to get in touch with your doctor as a professional advice is needed in this case regarding your health, medications and further recommendation to give you a stable health condition.

What other drugs will affect Relbovin (50mg)?

Tell your doctor about all other medications you use, especially:

This list is not complete and there may be other drugs that can interact with Relbovin (50mg). Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.

Who should not take Relbovin (50mg)?

You should not use this medication if you are allergic to it, or if you have severely low white blood cell counts.

If you have any of these other conditions, you may need a dose adjustment or special tests to safely use this medication:

FDA pregnancy category D. Relbovin (50mg) can cause harm to an unborn baby or cause birth defects. Before you receive Relbovin (50mg), tell your doctor if you are pregnant. Use an effective form of birth control, and tell your doctor if you become pregnant during treatment.

It is not known whether Relbovin (50mg) passes into breast milk or if it could harm a nursing baby. You should not breast-feed while you are being treated with Relbovin (50mg).

How should I take Relbovin (50mg)?

You should not use this medication if you are allergic to it, or if you have severely low white blood cell counts.

Do not use Relbovin (50mg) if you are pregnant. It could harm the unborn baby. Use effective birth control, and tell your doctor if you become pregnant during treatment.

Before you receive Relbovin (50mg), tell your doctor if you have liver disease, bone marrow suppression, a nerve disorder, or if you have received radiation therapy or other cancer treatments.

Relbovin (50mg) is sometimes used in combination with other cancer medications.

Tell your caregivers if you feel any burning, pain, or swelling around the IV needle when Relbovin (50mg) is injected.

Relbovin (50mg) can lower blood cells that help your body fight infections. Avoid being near people who have colds, the flu, or other contagious illnesses. Your blood will need to be tested on a regular basis. Do not miss any scheduled appointments. Contact your doctor at once if you develop signs of infection.

Do not receive a "live" vaccine while you are being treated with Relbovin (50mg), and avoid coming into contact with anyone who has recently received a live vaccine. There is a chance that the virus could be passed on to you.

Can Relbovin (50mg) be taken or consumed while pregnant?

Please visit your doctor for a recommendation as such case requires special attention.

Can Relbovin (50mg) be taken for nursing mothers or during breastfeeding?

Kindly explain your state and condition to your doctor and seek medical advice from an expert.

advertisement

Reviews

Following the study conducted by gmedication.com on Relbovin (50mg), the result is highlighted below. However, it must be clearly stated that the survey and result is based solely on the perception and impression of visitors and users of the website as well as consumers of Relbovin (50mg). We, therefore, urge readers not to base their medical judgment strictly on the result of this study but on test/diagnosis duly conducted by a certified medical practitioners or physician.

Patient reports

Patient reported useful

No survey data has been collected yet


Patient reported side effects

No survey data has been collected yet


Patient reported price estimates

No survey data has been collected yet


Patient reported frequency of use

No survey data has been collected yet


Patient reported doses

No survey data has been collected yet


Patient reported time for results

No survey data has been collected yet


Patient reported administration

No survey data has been collected yet


Patient reported age

No survey data has been collected yet


Patient reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 27 here

The information was verified by Dr. Vishal Pawar, MD Pharmacology